Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Oral retinoids can cause side effects ranging from mild to severe, including birth defects, and require careful monitoring and contraception.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

All types of Platelet-Rich Plasma (PRP) can treat hair loss, but homologous PRP works best due to its higher platelet count and growth factors from multiple donors.

Minoxidil promotes hair regrowth, but more research needed for effectiveness and response factors.

Unique fat cells near fibrotic areas contribute to systemic sclerosis progression.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

A young woman's Cronkhite-Canada syndrome improved on its own after she gave birth.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

The perception of excessive hair growth in women as abnormal is more influenced by cultural norms than by medical reasons.

COVID-19 may harm male fertility and damage the reproductive system.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Dermocosmetics help manage skin issues in cancer patients, improving outcomes and reducing treatment interruptions.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Microemulsions and nanoemulsions can effectively deliver drugs through the skin, but more research is needed to understand their differences and mechanisms.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Solanum nigrum shows promise for treating COVID-19 and its complications, but more research is needed.

The extract from Bacillus/Trapa japonica fruit helps increase hair growth and could be a potential treatment for hair loss.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Plant-based ingredients in hair care are being replaced by synthetic alternatives.

Malassezia furfur lipids improve skin health at pH 6.